Index -
P/E -
EPS (ttm) -1.52
Insider Own 17.14%
Shs Outstand 108.24M
Perf Week 12.59%
Market Cap 1.36B
Forward P/E -
EPS next Y -1.15
Insider Trans 0.05%
Shs Float 101.34M
Perf Month -24.30%
Income -182.63M
PEG -
EPS next Q -0.46
Inst Own 79.44%
Short Float 11.17%
Perf Quarter -30.64%
Sales 610.78M
P/S 2.22
EPS this Y 1.75%
Inst Trans 1.29%
Short Ratio 4.52
Perf Half Y -52.07%
Book/sh 5.81
P/B 1.91
EPS next Y 22.96%
ROA -19.39%
Short Interest 11.32M
Perf Year -73.15%
Cash/sh 3.22
P/C 3.45
EPS next 5Y 17.47%
ROE -25.17%
52W Range 9.27 - 42.85
Perf YTD -22.77%
Dividend Est. -
P/FCF -
EPS past 5Y -36.10%
ROI -23.31%
52W High -74.12%
Beta 1.93
Dividend TTM -
Quick Ratio 4.26
Sales past 5Y 21.90%
Gross Margin 70.09%
52W Low 19.63%
ATR (14) 0.94
Dividend Ex-Date -
Current Ratio 4.97
EPS Y/Y TTM 30.29%
Oper. Margin -31.47%
RSI (14) 41.40
Volatility 10.48% 8.51%
Employees 1306
Debt/Eq 0.12
Sales Y/Y TTM -1.28%
Profit Margin -29.90%
Recom 2.47
Target Price 16.00
Option/Short Yes / Yes
LT Debt/Eq 0.10
EPS Q/Q 2.35%
Payout -
Rel Volume 0.86
Prev Close 11.70
Sales Surprise 3.29%
EPS Surprise -33.65%
Sales Q/Q -10.30%
Earnings Feb 12 AMC
Avg Volume 2.50M
Price 11.09
SMA20 -2.65%
SMA50 -18.30%
SMA200 -36.90%
Trades
Volume 987,667
Change -5.21%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-13-25 Downgrade
Leerink Partners
Outperform → Market Perform
$25 → $12
Sep-03-24 Initiated
Leerink Partners
Outperform
$35
Jul-22-24 Upgrade
Jefferies
Hold → Buy
$24
Jul-18-24 Downgrade
JP Morgan
Overweight → Neutral
$40 → $20
Jul-10-24 Downgrade
Deutsche Bank
Buy → Hold
$55 → $25
Jun-27-24 Downgrade
Wolfe Research
Outperform → Peer Perform
Jun-25-24 Downgrade
Guggenheim
Buy → Neutral
Jun-03-24 Resumed
Jefferies
Hold
$24
May-01-24 Downgrade
TD Cowen
Buy → Hold
$57 → $32
Dec-14-23 Initiated
Guggenheim
Buy
$60
Dec-13-23 Initiated
Wolfe Research
Outperform
$55
Dec-12-23 Upgrade
BofA Securities
Underperform → Neutral
$36 → $54
Jul-05-23 Resumed
JP Morgan
Overweight
$65
May-10-23 Initiated
Barclays
Overweight
$65
Mar-31-23 Initiated
Stephens
Overweight
$65
Feb-02-23 Initiated
UBS
Neutral
$50
Dec-14-22 Initiated
Deutsche Bank
Buy
$50
Aug-18-22 Downgrade
Goldman
Neutral → Sell
$55 → $35
Jul-25-22 Initiated
Canaccord Genuity
Buy
$55
Jul-15-22 Downgrade
William Blair
Outperform → Mkt Perform
Show Previous Ratings
Mar-03-25 04:05PM
(PR Newswire) -7.86%
+6.80%
08:03AM
Feb-23-25 11:30AM
Feb-18-25 04:05PM
Feb-13-25 03:10PM
01:57PM
Loading…
01:57PM
01:53PM
09:42AM
07:36AM
(Thomson Reuters StreetEvents)
02:16AM
Feb-12-25 06:30PM
05:45PM
04:41PM
(Associated Press Finance)
04:39PM
04:05PM
09:15AM
Loading…
Feb-11-25 09:15AM
08:06AM
Feb-06-25 08:08PM
08:30AM
Feb-05-25 10:00AM
Jan-28-25 04:05PM
Jan-12-25 12:00PM
Jan-08-25 07:30PM
(The Wall Street Journal)
Jan-02-25 04:05PM
Dec-30-24 09:28AM
Dec-24-24 07:30AM
Dec-23-24 04:05PM
Nov-20-24 03:29PM
Nov-19-24 07:11PM
Nov-07-24 04:05PM
08:00AM
Loading…
Oct-31-24 08:00AM
Oct-30-24 07:36AM
(Thomson Reuters StreetEvents)
03:14AM
Oct-29-24 07:00PM
05:20PM
04:15PM
(Associated Press Finance)
04:05PM
Oct-23-24 12:00PM
Oct-22-24 10:01AM
Oct-15-24 04:05PM
Oct-10-24 04:14PM
01:26PM
07:36AM
Oct-09-24 05:57PM
04:05PM
Oct-04-24 05:05PM
Oct-01-24 04:05PM
(PR Newswire) -5.62%
-5.54%
Sep-10-24 09:00AM
Sep-03-24 04:05PM
Aug-22-24 04:05PM
Aug-12-24 03:01PM
Aug-08-24 06:00PM
05:45PM
04:45PM
(Associated Press Finance)
04:05PM
04:04PM
Aug-07-24 09:15AM
Aug-05-24 04:00PM
Aug-01-24 10:01AM
Jul-21-24 11:49PM
Jul-17-24 09:55AM
Jul-12-24 09:15AM
08:00AM
Jul-10-24 02:10PM
Jun-27-24 09:00AM
Jun-25-24 08:14AM
Jun-20-24 09:00AM
Jun-07-24 01:01PM
May-29-24 04:05PM
May-10-24 07:01AM
May-07-24 02:45PM
May-06-24 01:04PM
09:08AM
May-02-24 04:05PM
06:04AM
May-01-24 12:59PM
11:33AM
11:05AM
(Thomson Reuters StreetEvents)
03:27AM
01:01AM
Apr-30-24 08:57PM
06:30PM
05:43PM
04:38PM
(Associated Press Finance)
04:05PM
Apr-29-24 11:01AM
Apr-25-24 11:28AM
Apr-24-24 09:35AM
Apr-23-24 10:01AM
Apr-22-24 12:00PM
Apr-18-24 06:46AM
Apr-10-24 04:05PM
Mar-26-24 09:00AM
Mar-21-24 04:05PM
Mar-13-24 04:05PM
08:17AM
Mar-01-24 02:00PM
Feb-27-24 11:55AM
Feb-20-24 04:05PM
Feb-16-24 10:21AM
10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. The company's products include Single Cell Gene Expression, Immune Profiling, ATAC, and Genome. The company was founded by Serge Saxonov, Ben Hindson and Kevin D. Ness on July 2, 2012 and is headquartered in Pleasanton, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Saxonov Serge Chief Executive Officer Mar 04 '25 Option Exercise 1.20 50,000 60,000 921,540 Mar 04 06:50 PM Saxonov Serge Chief Executive Officer Feb 28 '25 Sale 10.63 7,942 84,393 871,540 Mar 04 06:50 PM Serge Saxonov Director, CEO Feb 28 '25 Proposed Sale 10.57 7,942 83,947 Feb 28 05:03 PM Hindson Benjamin J. See Remarks Feb 24 '25 Sale 11.07 4,573 50,603 335,324 Feb 26 05:43 PM Saxonov Serge Chief Executive Officer Feb 24 '25 Sale 11.07 5,092 56,346 879,482 Feb 26 05:42 PM MATEO ALAN Director Feb 21 '25 Buy 11.14 40,000 445,572 61,691 Feb 25 05:22 PM Saxonov Serge Officer Feb 24 '25 Proposed Sale 11.56 5,104 59,002 Feb 24 08:01 PM Hindson Benjamin J. Officer Feb 24 '25 Proposed Sale 11.56 4,563 52,748 Feb 24 07:35 PM Saxonov Serge Chief Executive Officer Dec 23 '24 Option Exercise 1.20 12,000 14,400 884,574 Dec 23 08:29 PM Saxonov Serge Chief Executive Officer Nov 22 '24 Sale 13.69 6,693 91,612 872,574 Nov 25 04:53 PM Hindson Benjamin J. See Remarks Nov 22 '24 Sale 13.69 5,807 79,485 339,897 Nov 25 04:52 PM Hindson Benjamin J. Officer Nov 22 '24 Proposed Sale 13.32 5,734 76,377 Nov 22 04:56 PM Saxonov Serge Officer Nov 22 '24 Proposed Sale 13.32 6,608 88,019 Nov 22 04:38 PM Saxonov Serge Chief Executive Officer Aug 22 '24 Sale 22.53 6,749 152,053 882,467 Aug 26 05:05 PM Hindson Benjamin J. See Remarks Aug 22 '24 Sale 22.53 4,351 98,027 345,704 Aug 26 05:04 PM McAnear Justin J. Former Chief Financial Officer Aug 22 '24 Sale 22.53 2,961 66,710 143,242 Aug 26 05:03 PM Saxonov Serge Officer Aug 22 '24 Proposed Sale 23.01 6,749 155,294 Aug 22 08:45 PM McAnear Justin J. Officer Aug 22 '24 Proposed Sale 23.01 2,961 68,133 Aug 22 08:42 PM Hindson Benjamin J. Officer Aug 22 '24 Proposed Sale 23.01 4,351 100,117 Aug 22 08:39 PM McAnear Justin J. Chief Financial Officer May 22 '24 Sale 24.30 2,936 71,355 146,203 May 23 07:54 PM Saxonov Serge Chief Executive Officer May 22 '24 Sale 24.30 4,877 118,529 889,641 May 23 07:53 PM Hindson Benjamin J. See Remarks May 22 '24 Sale 24.30 4,087 99,329 350,055 May 23 07:52 PM
Index -
P/E 56.41
EPS (ttm) 4.33
Insider Own 8.91%
Shs Outstand 162.35M
Perf Week 11.54%
Market Cap 39.65B
Forward P/E 30.25
EPS next Y 8.07
Insider Trans -0.02%
Shs Float 147.88M
Perf Month 2.00%
Income 714.14M
PEG 4.88
EPS next Q 1.74
Inst Own 80.78%
Short Float 2.76%
Perf Quarter 2.72%
Sales 2.75B
P/S 14.44
EPS this Y 10.87%
Inst Trans 2.37%
Short Ratio 3.44
Perf Half Y 13.42%
Book/sh 33.93
P/B 7.20
EPS next Y 10.32%
ROA 10.78%
Short Interest 4.09M
Perf Year 8.75%
Cash/sh 31.72
P/C 7.70
EPS next 5Y 11.55%
ROE 13.63%
52W Range 170.25 - 258.93
Perf YTD 16.15%
Dividend Est. -
P/FCF 37.59
EPS past 5Y 17.83%
ROI 12.11%
52W High -5.68%
Beta 1.06
Dividend TTM -
Quick Ratio 6.36
Sales past 5Y 20.27%
Gross Margin 75.64%
52W Low 43.44%
ATR (14) 8.20
Dividend Ex-Date -
Current Ratio 4.51
EPS Y/Y TTM 34.71%
Oper. Margin 25.17%
RSI (14) 63.99
Volatility 4.92% 2.92%
Employees 7172
Debt/Eq 0.01
Sales Y/Y TTM 16.20%
Profit Margin 26.00%
Recom 1.97
Target Price 265.96
Option/Short Yes / Yes
LT Debt/Eq 0.01
EPS Q/Q 31.34%
Payout 0.00%
Rel Volume 1.31
Prev Close 246.80
Sales Surprise 3.10%
EPS Surprise 8.84%
Sales Q/Q 14.31%
Earnings Mar 05 AMC
Avg Volume 1.19M
Price 244.21
SMA20 6.31%
SMA50 8.50%
SMA200 16.31%
Trades
Volume 716,960
Change -1.05%
Date
Action
Analyst
Rating Change
Price Target Change
Jan-23-25 Downgrade
Goldman
Buy → Sell
$261 → $200
Dec-20-24 Initiated
Stephens
Overweight
$280
Dec-04-24 Initiated
Mizuho
Outperform
$275
Nov-19-24 Initiated
Scotiabank
Sector Perform
$235
Oct-08-24 Initiated
Exane BNP Paribas
Outperform
$286
Aug-27-24 Reiterated
Citigroup
Buy
$256 → $273
Jul-09-24 Initiated
BTIG Research
Buy
$240
Oct-25-23 Upgrade
Wells Fargo
Equal Weight → Overweight
$211 → $229
Oct-13-23 Initiated
Jefferies
Buy
$265
Jun-28-23 Downgrade
Morgan Stanley
Equal-Weight → Underweight
$181
Jun-01-23 Upgrade
Guggenheim
Neutral → Buy
$226
Mar-17-23 Downgrade
Truist
Buy → Hold
$205 → $195
Feb-23-23 Downgrade
Guggenheim
Buy → Neutral
Jan-04-23 Upgrade
Barclays
Equal Weight → Overweight
$205
Dec-06-22 Initiated
Cowen
Market Perform
$184
Dec-02-22 Reiterated
Needham
Buy
$205 → $220
Oct-31-22 Initiated
Wells Fargo
Equal Weight
$180
Oct-19-22 Upgrade
JP Morgan
Underweight → Neutral
$225 → $170
Sep-16-22 Initiated
KeyBanc Capital Markets
Overweight
$220
Jul-27-22 Initiated
Oppenheimer
Outperform
$250
Show Previous Ratings
Mar-07-25 07:03PM
10:01AM
Mar-06-25 04:45PM
(Investor's Business Daily) +7.37%
02:29PM
01:38PM
12:56PM
Loading…
12:56PM
10:30AM
(Thomson Reuters StreetEvents)
09:57AM
09:38AM
(The Wall Street Journal)
02:11AM
Mar-05-25 11:30PM
06:00PM
05:15PM
04:27PM
(Associated Press Finance)
04:26PM
04:05PM
Loading…
04:05PM
12:00AM
Mar-04-25 09:18PM
03:05PM
08:04AM
07:03AM
Mar-03-25 07:03AM
Feb-28-25 05:45PM
09:30AM
09:15AM
05:21AM
Feb-27-25 09:00AM
07:03AM
Feb-21-25 05:45PM
Feb-19-25 05:50PM
01:08PM
Loading…
Feb-14-25 01:08PM
Feb-12-25 04:05PM
09:00AM
Feb-11-25 09:30AM
Feb-10-25 05:45PM
Feb-04-25 07:03AM
Feb-03-25 05:45PM
Jan-29-25 09:00AM
07:03AM
Jan-27-25 05:45PM
Jan-26-25 06:01AM
Jan-24-25 05:50PM
Jan-23-25 07:03AM
03:45AM
Jan-16-25 05:50PM
09:00AM
Jan-14-25 09:26AM
Jan-13-25 01:30PM
Jan-10-25 05:45PM
Jan-09-25 04:04AM
Dec-31-24 09:45AM
Dec-26-24 09:00AM
Dec-24-24 10:32AM
Dec-18-24 02:42PM
(Investor's Business Daily)
Dec-16-24 07:07PM
05:22PM
Dec-14-24 07:30AM
Dec-12-24 09:45AM
09:00AM
07:03AM
04:07AM
Dec-11-24 10:41PM
(Morningstar Research) -5.01%
09:15AM
Dec-10-24 03:10PM
09:44AM
Dec-09-24 10:30AM
Dec-06-24 06:36PM
(Morningstar Research) +8.11%
09:50AM
(Thomson Reuters StreetEvents)
05:04AM
02:04AM
12:15AM
Dec-05-24 10:13PM
06:00PM
05:25PM
04:24PM
04:22PM
(Associated Press Finance)
04:05PM
Dec-04-24 08:00PM
02:09AM
Dec-02-24 01:29PM
Nov-29-24 09:30AM
Nov-28-24 12:10PM
10:00AM
09:00AM
Nov-27-24 11:04AM
Nov-26-24 05:45PM
Nov-24-24 09:40PM
Nov-21-24 07:03AM
04:30AM
Nov-20-24 04:00AM
Nov-19-24 07:03AM
Nov-18-24 05:45PM
Nov-17-24 08:00PM
Nov-14-24 04:14PM
10:03AM
09:00AM
07:03AM
Nov-12-24 09:30AM
Nov-11-24 05:45PM
04:03AM
Veeva Systems, Inc. engages in the provision of industry cloud solutions for the global life sciences industry. Its solutions enable pharmaceutical and other life sciences companies to realize the benefits of modern cloud-based architectures and mobile applications for their most critical business functions, without compromising industry-specific functionality or regulatory compliance. The firm's customer relationship management solutions enable its customers to increase the productivity and compliance of their sales and marketing functions. Its regulated content management and collaboration solutions enable its customers to more efficiently manage regulated, content-centric processes across the enterprise. The company's customer master solution enables customers to more effectively manage complex healthcare provider and healthcare organization data. The company was founded by Mark Armenante, Peter P. Gassner, Doug Ostler, Mitch Wallace and Matthew J. Wallach on January 12, 2007, and is headquartered in Pleasanton, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Carges Mark T Director Mar 01 '25 Option Exercise 0.00 356 0 356 Mar 03 07:17 PM Cabral Timothy S Director Mar 01 '25 Option Exercise 0.00 314 0 314 Mar 03 07:16 PM Hedley Mary Lynne Director Mar 01 '25 Option Exercise 0.00 342 0 5,760 Mar 03 07:15 PM Hung Priscilla Director Mar 01 '25 Option Exercise 0.00 342 0 3,966 Mar 03 07:14 PM Hunt Nimrata Director Mar 01 '25 Option Exercise 0.00 342 0 3,859 Mar 03 07:13 PM MOHR MARSHALL Director Mar 01 '25 Option Exercise 0.00 384 0 4,436 Mar 03 07:12 PM Ritter Gordon Director Mar 01 '25 Option Exercise 0.00 398 0 398 Mar 03 07:11 PM SEKHRI PAUL J Director Mar 01 '25 Option Exercise 0.00 328 0 16,340 Mar 03 07:10 PM Wallach Matthew J Director Mar 01 '25 Option Exercise 0.00 328 0 105,591 Mar 03 07:08 PM Van Wagener Brian Chief Financial Officer Jan 01 '25 Option Exercise 0.00 1,370 0 6,047 Jan 03 05:10 PM Schwenger Thomas D. Pres. & Chief Customer Officer Jan 01 '25 Option Exercise 0.00 1,909 0 28,922 Jan 03 05:09 PM DIAMOND KRISTINE Chief Accounting Officer Jan 01 '25 Option Exercise 0.00 203 0 822 Jan 03 05:08 PM Zuppas Eleni Nitsa President & Chief of Staff Jan 01 '25 Option Exercise 0.00 1,323 0 23,296 Jan 03 05:07 PM Faddis Jonathan SVP, Gen. Counsel, Secretary Jan 01 '25 Option Exercise 0.00 1,120 0 9,181 Jan 03 05:05 PM Faddis Jonathan SVP, Gen. Counsel, Secretary Dec 04 '24 Sale 230.30 1,694 390,128 8,061 Dec 06 04:17 PM Faddis Jonathan Officer Dec 04 '24 Proposed Sale 230.30 1,694 390,128 Dec 04 04:18 PM Cabral Timothy S Director Dec 01 '24 Option Exercise 0.00 315 0 1,741 Dec 02 05:02 PM Hedley Mary Lynne Director Dec 01 '24 Option Exercise 0.00 343 0 5,418 Dec 02 05:01 PM Hung Priscilla Director Dec 01 '24 Option Exercise 0.00 343 0 3,624 Dec 02 05:01 PM Wallach Matthew J Director Dec 01 '24 Option Exercise 0.00 329 0 105,263 Dec 02 05:00 PM SEKHRI PAUL J Director Dec 01 '24 Option Exercise 0.00 329 0 16,012 Dec 02 04:59 PM Ritter Gordon Director Dec 01 '24 Option Exercise 0.00 399 0 1,501 Dec 02 04:59 PM MOHR MARSHALL Director Dec 01 '24 Option Exercise 0.00 385 0 4,052 Dec 02 04:58 PM Hunt Nimrata Director Dec 01 '24 Option Exercise 0.00 343 0 3,517 Dec 02 04:57 PM Carges Mark T Director Dec 01 '24 Option Exercise 0.00 357 0 357 Dec 02 04:57 PM Schwenger Thomas D. Pres. & Chief Customer Officer Nov 08 '24 Sale 240.01 1,126 270,252 27,013 Nov 12 10:48 AM Schwenger Thomas D. Director Nov 08 '24 Proposed Sale 240.01 1,126 270,252 Nov 08 12:28 PM Zuppas Eleni Nitsa President & Chief of Staff Oct 01 '24 Option Exercise 0.00 1,324 0 22,645 Oct 02 05:58 PM Schwenger Thomas D. Pres. & Chief Customer Officer Oct 01 '24 Option Exercise 0.00 1,909 0 28,974 Oct 02 05:55 PM DIAMOND KRISTINE Chief Accounting Officer Oct 01 '24 Option Exercise 0.00 204 0 692 Oct 02 05:54 PM Faddis Jonathan SVP, Gen. Counsel, Secretary Oct 01 '24 Option Exercise 0.00 1,120 0 10,155 Oct 02 05:53 PM Cabral Timothy S Interim CFO Sep 01 '24 Option Exercise 0.00 315 0 1,426 Sep 03 05:56 PM Carges Mark T Director Sep 01 '24 Option Exercise 0.00 357 0 357 Sep 03 05:00 PM Hedley Mary Lynne Director Sep 01 '24 Option Exercise 0.00 343 0 5,075 Sep 03 04:57 PM Hung Priscilla Director Sep 01 '24 Option Exercise 0.00 343 0 3,281 Sep 03 04:56 PM Hunt Nimrata Director Sep 01 '24 Option Exercise 0.00 343 0 3,174 Sep 03 04:55 PM MOHR MARSHALL Director Sep 01 '24 Option Exercise 0.00 385 0 3,667 Sep 03 04:53 PM Ritter Gordon Director Sep 01 '24 Option Exercise 0.00 399 0 1,102 Sep 03 04:52 PM SEKHRI PAUL J Director Sep 01 '24 Option Exercise 0.00 329 0 15,683 Sep 03 04:51 PM Wallach Matthew J Director Sep 01 '24 Option Exercise 0.00 329 0 104,934 Sep 03 04:49 PM Faddis Jonathan SVP, Gen. Counsel, Secretary Aug 21 '24 Sale 200.00 2,353 470,600 9,035 Aug 21 05:10 PM Faddis Jonathan Officer Aug 21 '24 Proposed Sale 200.00 2,353 470,600 Aug 21 04:27 PM Epstein Stacey Chief Marketing Officer Jul 01 '24 Option Exercise 0.00 891 0 891 Jul 02 05:21 PM Zuppas Eleni Nitsa President & Chief of Staff Jul 01 '24 Option Exercise 0.00 1,324 0 21,321 Jul 02 05:21 PM Schwenger Thomas D. Pres. & Chief Customer Officer Jul 01 '24 Option Exercise 0.00 1,909 0 27,867 Jul 02 05:21 PM DIAMOND KRISTINE Chief Accounting Officer Jul 01 '24 Option Exercise 0.00 204 0 561 Jul 02 05:21 PM Faddis Jonathan SVP, Gen. Counsel, Secretary Jul 01 '24 Option Exercise 0.00 1,120 0 11,788 Jul 02 05:21 PM Cabral Timothy S Interim CFO Jun 07 '24 Sale 184.33 15,000 2,764,931 8,391 Jun 07 05:53 PM Hung Priscilla Director Jun 01 '24 Option Exercise 0.00 302 0 2,938 Jun 03 05:12 PM Cabral Timothy S Director Jun 01 '24 Option Exercise 0.00 278 0 1,111 Jun 03 05:11 PM Carges Mark T Director Jun 01 '24 Option Exercise 0.00 315 0 315 Jun 03 05:10 PM Hedley Mary Lynne Director Jun 01 '24 Option Exercise 0.00 302 0 4,732 Jun 03 05:09 PM Hunt Nimrata Director Jun 01 '24 Option Exercise 0.00 302 0 2,831 Jun 03 05:09 PM MOHR MARSHALL Director Jun 01 '24 Option Exercise 0.00 339 0 3,282 Jun 03 05:08 PM Ritter Gordon Director Jun 01 '24 Option Exercise 0.00 352 0 703 Jun 03 05:08 PM SEKHRI PAUL J Director Jun 01 '24 Option Exercise 0.00 290 0 15,354 Jun 03 05:07 PM Wallach Matthew J Director Jun 01 '24 Option Exercise 0.00 290 0 104,605 Jun 03 05:06 PM MATEO ALAN EVP Global Sales Apr 23 '24 Sale 200.86 3,391 681,116 21,983 Apr 23 07:09 PM Faddis Jonathan SVP, Gen. Counsel, Secretary Apr 15 '24 Sale 207.42 3,598 746,297 10,668 Apr 16 04:33 PM Schwenger Thomas D. President and COO Apr 01 '24 Option Exercise 0.00 2,268 0 26,610 Apr 02 03:51 PM Zuppas Eleni Nitsa Chief Marketing Officer Apr 01 '24 Option Exercise 0.00 1,620 0 20,677 Apr 02 03:49 PM MATEO ALAN EVP Global Sales Apr 01 '24 Option Exercise 0.00 6,944 0 26,983 Apr 02 03:47 PM DIAMOND KRISTINE Chief Accounting Officer Apr 01 '24 Option Exercise 0.00 220 0 435 Apr 02 03:44 PM Bowman Brent R Former Chief Financial Officer Apr 01 '24 Option Exercise 0.00 1,296 0 9,287 Apr 02 03:43 PM Faddis Jonathan SVP, Gen. Counsel, Secretary Apr 01 '24 Option Exercise 0.00 1,296 0 19,729 Apr 02 03:41 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite